The safety of central line placement prior to treatment of pediatric acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 47, Issue 7, 2006, Pages 886-888

  Carr, Emily ^a   Jayabose, Somasundaram ^a   Stringel, Gustavo ^a   Slim, Michel ^a   Ozkaynak, M Fevzi ^a   Tugal, Oya ^a   Sandoval, Claudio ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Acute lymphoblastic leukemia; Central lines; Safety

Indexed keywords

ASPARAGINASE; CEFOTAXIME; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; HYDROCORTISONE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANESTHESIA INDUCTION; BLOOD CELL COUNT; BLOOD TRANSFUSION; CENTRAL VENOUS CATHETERIZATION; CHILD; DEVICE REMOVAL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; NEUTROPENIA; NEUTROPHIL COUNT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SAFETY; SCHOOL CHILD; THROMBOCYTE COUNT; WOUND DEHISCENCE; WOUND INFECTION;

ADOLESCENT; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; RETROSPECTIVE STUDIES;

EID: 33750451975     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20629     Document Type: Review

References (11)

1. Schrappe M, Reiter A, Zimmermann M, et al. Long-term result of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia 2000;14:2205-2222.
2. Stork LC, Sather HN, Nachman JB, et al. Intensive therapy "rescues" children with standard risk ALL (SR-ALL) and slow early response to induction: CCG-1952 report. Proc ASCO 2001;20:370a.
3. Steinherz PG, Gaynon P, Miller DR, et al. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen-A new intensive therapy protocol: A report from the Children's Cancer Study Group. J Clin Oncol 1986;4:744-752.
4. Nachman J, Seibel NL, Sather H, et al. Outcome for adolescent and young adults patients with acute lymphoblastic leukemia treated on the Children's Cancer Group 1961 study. Blood 2004;104:196a.
5. Fratino G, Molinari AC, Mazzola C, et al. Prospective study of indwelling central venous catheter-related complications in children with Broviac or clampless valved catheters. J Pediatr Hematol Oncol 2002;24:657-661.
6. Journeycake JM, Buchanan GR. Thrombotic complications of central venous catheters in children. Curr Opin Hematol 2003;10:369-374.
7. Freytes CO. Thromboembolic complications related to indwelling central venous catheters in children. Curr Opin Oncol 2003;15:289-292.
8. Rackoff WR, Ge J, Sather HN, et al. Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: A report from the Children's Cancer Group. J Pediatr Hematol Oncol 1999;21:260-267.
9. McLean TW, Fisher CJ, Snively BM, et al. Central venous lines in children with lesser risk acute lymphoblastic leukemia: Optimal type and timing of placement. J Clin Oncol 2005;23:3024-3029.
10. Abbas AA, Fryer CJ, Paltiel C, et al. Factors influencing central line infections in children with acute lymphoblastic leukemia: Results of a single institutional study. Pediatr Blood Cancer 2004;42:325-331.
11. Shaul DB, Scheer B, Rokhsar S, et al. Risk factors for early infection of central venous catheters in pediatric patients. J Am Coll Surg 1998;186:654-658.